酮康唑
生物
白色念珠菌
棘白菌素
抗真菌药
抗药性
钙调神经磷酸酶
流出
药物耐受性
唑
白色体
药品
药理学
微生物学
氟康唑
抗真菌
遗传学
医学
移植
内科学
作者
Yi Xu,Hui Lu,Shuo Zhu,Wan-Qian Li,Yuanying Jiang,Judith G. Berman,Feng Yang
出处
期刊:Microbiology spectrum
[American Society for Microbiology]
日期:2021-06-23
卷期号:9 (1): e0032121-e0032121
被引量:35
标识
DOI:10.1128/spectrum.00321-21
摘要
Due to the ever-expanding range of invasive medical procedures and treatments, invasive fungal infections now pose a serious global threat to many people living in an immunocompromised status. Like humans, fungi are eukaryotic, which significantly limits the number of unique antifungal targets; the current arsenal of antifungal agents is limited to just three frontline drug classes. Additional treatment complexities result from the development of drug tolerance and resistance, which further narrows therapeutic options; however, the difference between tolerance and resistance remains largely unknown. This study demonstrates that tolerance and resistance are regulated by multiple genetic and physiological factors. It is prudent to note that some factors affect tolerance only, while other factors affect both tolerance and resistance. The complex underlying mechanisms of these drug responses are highlighted by the fact that there are both shared and distinct mechanisms that regulate tolerance and resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI